Skip to main content
Caplight Logo









Symbiome

Symbiome

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://symbiome.com/

Last Round

VC Round

Oct 31, 2022

Total Funding Raised

$18M

Company Overview

Symbiome is a skincare company that produces science-based, microbiome-focused beauty products using sustainably sourced Amazonian ingredients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

microbiome skincareskin microbiomeclean beautypostbiotic skincareDTC skincaremicrobiome-friendlybiotech skincareskin healthancestral skincareskincare sciencedermatology-consciousclinical skincareskin barrier supportmicrobiome healthbiohacking beauty

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbiome Comparables

Compare Symbiome with similar companies based on industry and business-model similarity.

Symbiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AOBiome Therapeutics Inc.
83%
Glowbiotics
83%
Marie Veronique
81%

Symbiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 31, 2022
Series ASep 14, 2020
DebtJun 1, 2020

Key People

Founding team and executive leadership

Mads Hansen

Chief Product Officer

Executive Team

Symbiome Investors

Notable investors and investment history

Symbiome investors
InvestorRounds
GISEVSeries A
BOLD Capital PartnersSeries A
True VenturesPre Seed, Series A
Mission Bay CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 78% MoM, reaching 7.8K.

  • May 2, 2025

    Monthly visitors increased 76% to 15,000.

Symbiome Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Symbiome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Symbiome's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2017
Last FundingOct 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?